Should we abandon the use of prophylactic PD stents to prevent post-ERCP pancreatitis?
Am J Gastroenterol
.
2014 Aug;109(8):1292.
doi: 10.1038/ajg.2014.160.
Author
Anand R Kumar
1
Affiliation
1
Department of Gastroenterology, Einstein Medical Center Philadelphia, Philadelphia, Pennsylvania, USA.
PMID:
25091251
DOI:
10.1038/ajg.2014.160
No abstract available
Publication types
Letter
Comment
MeSH terms
Cholangiopancreatography, Endoscopic Retrograde / adverse effects*
Humans
Indomethacin / therapeutic use*
Nitrates / therapeutic use*
Pancreatitis / prevention & control*
Substances
Nitrates
Indomethacin